5 Questions on CDC Updates to COVID-19 and Flu Vaccine Guidance
Updates to CDC recommendations on influenza and COVID-19 vaccines and vaccine formulations will impact your choices during flu season this year.
©Kateryna_Kon/Shutterstock.com
New COVID-19 and influenza immunization recommendations from the Centers for Disease Control and Prevention (CDC) will affect vaccination decisions made during the 2023-2024 respiratory virus season. The updates reflect changes in the spread of infections as well as in the development of vaccines. The following 5 questions test what you know about recommended vaccines and vaccine formulations for these 2 soon-to-be-prevalent viruses.
Question 1. COVID-19 vaccination is recommended for everyone 6 months and older who is not immunocompromised.
Question 2. Which of the following COVID-19 vaccines is/are not currently recommended?
Question 3. With the development of bivalent COVID-19 vaccines, monovalent vaccines will not be used in 2023.
Question 4. Select recommended option(s) for persons aged ≥18 years who were previously vaccinated with the Janssen adenovirus vector COVID-19 vaccine.
Question 5. Select influenza vaccine(s) preferred by the CDC for those aged ≥65 years.
Sources include the 2023 CDC Immunization Schedules for adult- and children and subsequent, interim considerations of the CDC, as well as recent meetings of the CDC's Advisory Committee on Immunization Practices ( ACIP) and the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC).
Recent Videos
Related Content
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025Article
The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.
